Medistim ASA
F:MD1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Medistim ASA
F:MD1
|
NO |
Intrinsic Value
The intrinsic value of 
Medistim ASA (MD1) under the Base Case is 21.65 EUR per share.
Compared with the current market price of 26.6 EUR, the stock appears
Overvalued by 19% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Medistim ASA Does
Medistim ASA makes medical devices that help surgeons check blood flow and verify the quality of a repair while an operation is still underway. Its main products are ultrasound and flow-measurement systems, along with probes and related accessories used in heart, vascular, and other delicate surgeries. Hospitals and surgical teams buy these tools to reduce the chance of a bad connection or blocked vessel before a patient leaves the operating room.
- Headquarters
- Norway NO
- Employees
- 159
- IPO date
- May 28, 2004
Medistim has a narrow economic moat
Medistim ASA has a narrow economic moat, offering limited protection against competitors and some ability to sustain profitability.
Read the full moat analysisLatest Earnings Call
- EPS
- kr2.85
- Expected
- kr2.22
- Surprise
- +28.4%
- Stock, next trading day
- +0.9%
Revenue & Expenses Breakdown
Medistim ASA
Earnings Waterfall
Medistim ASA
The intrinsic value for Medistim ASA (MD1) under the Base Case is 21.65 EUR.
Compared with the current market price of 26.6 EUR, the stock appears Overvalued by 19% .